|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4035 | |
| A61P 35/00 | |||
| C07K 16/28 | |||
| A61K 39/395 |
| (11) | Number of the document | 2301535 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11151126.7 |
| Date of filing the European patent application | 2006-08-31 | |
| (97) | Date of publication of the European application | 2011-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 712823 P | 2005-09-01 | US |
| (72) |
Bartlett, Justin B., US
Muller, George W., US
Schafer, Peter H., US
Galustian, Christine, GB
Dalgleish, Angus C., GB
Meyer, Brendan, GB
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit New Jersey 07901,
US
|
| (54) | Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy |
| Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy |